14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Clovis Oncology prices

Date Open High Low Close Volume
Aug 23, 2016 $18.30 $24.97 $16.61 $23.03 17 276 500
Aug 22, 2016 $18.00 $18.45 $17.61 $18.10 2 384 000
Aug 19, 2016 $17.22 $17.29 $16.74 $17.25 759 400
Aug 18, 2016 $17.13 $17.49 $16.81 $17.25 571 700
Aug 17, 2016 $17.52 $17.69 $16.58 $17.20 1 016 000
Aug 16, 2016 $17.65 $17.73 $17.10 $17.46 763 200
Aug 15, 2016 $16.94 $17.79 $16.72 $17.67 1 086 300
Aug 12, 2016 $16.12 $16.93 $15.87 $16.87 862 900
Aug 11, 2016 $15.99 $16.25 $15.41 $16.21 767 100
Aug 10, 2016 $16.52 $16.65 $15.80 $15.90 659 500
Aug 09, 2016 $15.85 $16.96 $15.21 $16.55 1 373 400
Aug 08, 2016 $17.49 $17.75 $15.55 $15.69 1 477 800
Aug 05, 2016 $15.90 $17.80 $15.60 $17.41 2 868 900
Aug 04, 2016 $15.30 $15.74 $15.04 $15.44 975 400
Aug 03, 2016 $14.62 $15.35 $14.62 $15.23 788 700
Aug 02, 2016 $14.98 $15.05 $13.98 $14.67 840 000
Aug 01, 2016 $14.40 $15.10 $14.36 $15.04 805 600
Jul 29, 2016 $13.96 $14.50 $13.71 $14.28 401 000
Jul 28, 2016 $14.54 $14.69 $13.92 $14.03 445 200
Jul 27, 2016 $14.04 $14.54 $13.94 $14.49 593 400
Jul 26, 2016 $13.82 $14.00 $13.43 $13.96 635 400
Jul 25, 2016 $14.23 $14.37 $13.88 $13.91 545 200
Jul 22, 2016 $14.65 $14.97 $14.12 $14.19 508 300
Jul 21, 2016 $14.62 $15.12 $14.35 $14.54 800 000
Jul 20, 2016 $14.24 $14.57 $13.97 $14.55 693 900
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT